An immune exhaustion signature predicts prognosis and identifies patients with diffuse large B-cell lymphoma (DLBCL) who derive preferential benefit from chimeric antigen receptor (CAR)-T cell therapy
An immune exhaustion signature predicts prognosis and identifies patients with diffuse large B-cell lymphoma (DLBCL) who derive preferential benefit from chimeric antigen receptor (CAR)-T cell therapy
AI model enables over a million-fold acceleration of diffuse optical tomography for real-time diagnosis - EurekAlert!
Half of the universe’s hydrogen gas, long unaccounted for, has been found: « New measurements of the diffuse ionized hydrogen surrounding galaxies account for missing mass. »
